NewAmsterdam Pharma (NASDAQ:NAMSW) Short Interest Update

NewAmsterdam Pharma (NASDAQ:NAMSW) saw a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 100 shares, a decrease of 50.0% from the December 31st total of 200 shares. Based on an average daily volume of 6,200 shares, the days-to-cover ratio is presently 0.0 days.

NewAmsterdam Pharma Price Performance

NASDAQ NAMSW traded up $0.27 on Thursday, hitting $10.00. The stock had a trading volume of 4,950 shares, compared to its average volume of 1,741. The company’s 50-day moving average is $12.28 and its two-hundred day moving average is $9.70. NewAmsterdam Pharma has a one year low of $5.52 and a one year high of $16.75.

NewAmsterdam Pharma Company Profile

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases.